Module

Therapy of Chronic Hepatitis B: Who to Treat and When to Treat? A Case-Based Discussion

Source: Hepatitis Annual Update 2008

Therapy of Chronic Hepatitis B: Who to Treat and When to Treat? A Case-Based Discussion


Co-Chair: Norah Terrault, MD, MPH

Faculty:

  • Anna S. F. Lok, MD

CME CREDIT INFORMATION

Release Date: 06/20/08

Expiration Date: 06/19/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)

Registered Nurses: 0.8 Nursing CE credit

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe management strategies for the treatment of chronic hepatitis B in various case scenarios
  • Identify characteristics used to determine when treatment should be delayed or initiated in patients with chronic hepatitis B
  • Discuss treatment guidelines for chronic hepatitis B

Topics covered include:

  • Who to Treat and When to Treat
  • Clear-cut Cases in Which Treatment Should Be Initiated
  • Clear-cut Cases in Which Treatment Can Be Deferred
  • Cases Where The Treatment Decision Must Be Individualized
  • Summary: Implications for Clinical Practice
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.